Search Results - "Mautner, Victor Felix"

Refine Results
  1. 1

    Assessment of small fiber neuropathy in patients carrying the non‐classical Fabry variant p.D313Y by Cossel, Katharina, Muschol, Nicole, Friedrich, Reinhard E., Glatzel, Markus, Ammer, Luise, Lohmöller, Benjamin, Bendszus, Martin, Mautner, VictorFelix, Godel, Tim

    Published in Muscle & nerve (01-05-2021)
    “…Introduction The pathophysiological significance of the Fabry‐related, non‐classical variant p.D313Y still remains to be solved. This study assesses the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Asymmetry of thalamic hypometabolism on FDG‐PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden by Özden, Cansu, Mautner, VictorFelix, Farschtschi, Said, Molwitz, Isabel, Ristow, Inka, Bannas, Peter, Well, Lennart, Klutmann, Susanne, Adam, Gerhard, Apostolova, Ivayla, Buchert, Ralph

    Published in Journal of neuroimaging (01-01-2024)
    “…Background and Purpose Thalamic hypometabolism is a consistent finding in brain PET with F‐18 fluorodeoxyglucose (FDG) in patients with neurofibromatosis type…”
    Get full text
    Journal Article
  4. 4

    Dorsal root ganglia volume differentiates schwannomatosis and neurofibromatosis 2 by Godel, Tim, Mautner, VictorFelix, Farschtschi, Said, Pham, Mirko, Schwarz, Daniel, Kronlage, Moritz, Gugel, Isabel, Heiland, Sabine, Bendszus, Martin, Bäumer, Philipp

    Published in Annals of neurology (01-04-2018)
    “…Schwannomatosis and neurofibromatosis type 2 are hereditary tumor syndromes, and peripheral neuropathy has been reported in both. We prospectively applied in…”
    Get full text
    Journal Article
  5. 5

    Null phenotype of neurofibromatosis type 1 in a carrier of a heterozygous atypical NF1 deletion due to mosaicism by Kluwe, Lan, Friedrich, Reinhard E., Farschtschi, Said C., Hagel, Christian, Kehrer‐Sawatzki, Hildegard, Mautner, VictorFelix

    Published in Human mutation (01-07-2020)
    “…We coincidently detected an atypical deletion of at least 1.3‐Mb, encompassing the NF1 tumor suppressor gene and several adjacent genes at an apparent…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth by Well, Lennart, Döbel, Kimberly, Kluwe, Lan, Bannas, Peter, Farschtschi, Said, Adam, Gerhard, Mautner, Victor-Felix, Salamon, Johannes

    Published in PLoS genetics (05-05-2021)
    “…Neurofibromatosis type-1 (NF1) patients suffer from cutaneous and subcutaneous neurofibromas (CNF) and large plexiform neurofibromas (PNF). Whole gene…”
    Get full text
    Journal Article
  8. 8

    Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis by Farschtschi, Said C., Kluwe, Lan, Schön, Gerhard, Friedrich, Reinhard E., Matschke, Jakob, Glatzel, Markus, Weis, Joachim, Hagel, Christian, Mautner, VictorFelix

    Published in Brain pathology (Zurich, Switzerland) (01-03-2020)
    “…Schwannomatosis and neurofibromatosis type 2 (NF2) are two distinct neuro‐genetic tumor predisposition disorders, which, however, share some clinical and…”
    Get full text
    Journal Article
  9. 9

    Supportive care needs of patients with rare chronic diseases: multi-method, cross-sectional study by Depping, Miram K, Uhlenbusch, Natalie, von Kodolitsch, Yskert, Klose, Hans F E, Mautner, Victor-Felix, Löwe, Bernd

    Published in Orphanet journal of rare diseases (22-01-2021)
    “…In the absence of a cure for the majority of rare diseases, the disease management aims to provide optimal supportive care. The goal of this study was to…”
    Get full text
    Journal Article
  10. 10

    Ultra-deep amplicon sequencing indicates absence of low-grade mosaicism with normal cells in patients with type-1 NF1 deletions by Summerer, Anna, Schäfer, Eleonora, Mautner, Victor-Felix, Messiaen, Ludwine, Cooper, David N., Kehrer-Sawatzki, Hildegard

    Published in Human genetics (01-01-2019)
    “…Different types of large NF1 deletion are distinguishable by breakpoint location and potentially also by the frequency of mosaicism with normal cells lacking…”
    Get full text
    Journal Article
  11. 11

    White matter is increased in the brains of adults with neurofibromatosis 1 by Wang, Su, Friedman, Jan M, Suppa, Per, Buchert, Ralph, Mautner, Victor-Felix

    Published in Orphanet journal of rare diseases (05-03-2022)
    “…Neurofibromatosis 1 (NF1) is a rare autosomal dominant disease characterized by increased Schwann cell proliferation in peripheral nerves. Several small…”
    Get full text
    Journal Article
  12. 12

    Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target by Farschtschi, Said, Kluwe, Lan, Park, Su-Jin, Oh, Su-Jun, Mah, Nancy, Mautner, Victor-Felix, Kurtz, Andreas

    Published in Cancer Immunology, Immunotherapy (01-07-2020)
    “…Background Malignant peripheral nerve sheath tumors (MPNSTs) are rare aggressive sarcomas with poor prognosis. More than half of MPNSTs develop from benign…”
    Get full text
    Journal Article
  13. 13

    Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI by Well, Lennart, Careddu, Anna, Stark, Maria, Farschtschi, Said, Bannas, Peter, Adam, Gerhard, Mautner, Victor-Felix, Salamon, Johannes

    Published in Scientific reports (19-08-2021)
    “…Neurofibromatosis Type 1 (NF1) has been reported to be associated with a variety of spinal abnormalities. The purpose of this study was to quantify the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools by Kollmann, Philipp, Mautner, Victor-Felix, Koeppen, Johannes, Wenzel, Ralph, Friedman, Jan M., Salamon, Johannes, Farschtschi, Said

    Published in Scientific reports (14-07-2020)
    “…Neurofibromatosis type 2 is a neurogenetic disorder with an incidence of about 1:33.000. Hallmarks are bilateral benign vestibular schwannomas, which can lead…”
    Get full text
    Journal Article
  16. 16

    The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1 by LIDZBA, KAREN, GRANSTRÖM, SOFIA, LINDENAU, JORGE, MAUTNER, VICTOR-FELIX

    Published in Developmental medicine and child neurology (01-10-2012)
    “…Aim  A substantial proportion of patients with neurofibromatosis type 1 (NF1) have attention‐deficit disorder with or without hyperactivity (AD[H]D). This…”
    Get full text
    Journal Article
  17. 17

    Atypical NF1 Microdeletions: Challenges and Opportunities for Genotype/Phenotype Correlations in Patients with Large NF1 Deletions by Kehrer-Sawatzki, Hildegard, Wahlländer, Ute, Cooper, David N, Mautner, Victor-Felix

    Published in Genes (19-10-2021)
    “…Patients with neurofibromatosis type 1 (NF1) and type 1 deletions often exhibit more severe clinical manifestations than patients with intragenic gene…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20